JP2005514335A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005514335A5 JP2005514335A5 JP2003535832A JP2003535832A JP2005514335A5 JP 2005514335 A5 JP2005514335 A5 JP 2005514335A5 JP 2003535832 A JP2003535832 A JP 2003535832A JP 2003535832 A JP2003535832 A JP 2003535832A JP 2005514335 A5 JP2005514335 A5 JP 2005514335A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- gly
- compound according
- pacap
- natural
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US34451101P | 2001-10-19 | 2001-10-19 | |
| PCT/US2002/033904 WO2003033030A1 (en) | 2001-10-19 | 2002-10-21 | Pacap compositions and methods for tumor imaging and therapy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005514335A JP2005514335A (ja) | 2005-05-19 |
| JP2005514335A5 true JP2005514335A5 (enExample) | 2006-02-02 |
Family
ID=23350835
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003535832A Pending JP2005514335A (ja) | 2001-10-19 | 2002-10-21 | 腫瘍イメージング及び治療のためのｐａｃａｐ組成物及び方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US6855308B2 (enExample) |
| EP (1) | EP1441773A1 (enExample) |
| JP (1) | JP2005514335A (enExample) |
| KR (1) | KR20040055784A (enExample) |
| CN (1) | CN1571680A (enExample) |
| CA (1) | CA2464002C (enExample) |
| IL (1) | IL161332A0 (enExample) |
| RU (1) | RU2004115104A (enExample) |
| WO (1) | WO2003033030A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050009739A1 (en) * | 2002-02-14 | 2005-01-13 | Wei Wang | Formulation strategies in stabilizing peptides in organic solvents and in dried states |
| US9006181B2 (en) | 2004-07-21 | 2015-04-14 | The Administrators Of The Tulane Educational Fund | Treatment of renal dysfunction and multiple myeloma using PACAP compounds |
| WO2011013703A1 (ja) * | 2009-07-31 | 2011-02-03 | 独立行政法人理化学研究所 | 膵臓内分泌細胞用指示薬、及びその利用 |
| JP5908406B2 (ja) | 2009-11-02 | 2016-04-26 | ジ アドミニストレーターズ オブ ザ トゥレーン エデュケーショナル ファンド | 下垂体アデニル酸シクラーゼ活性化ポリペプチド（ｐａｃａｐ）の類似体およびその使用方法 |
| ES2667119T3 (es) * | 2010-06-24 | 2018-05-09 | Genomictree, Inc. | Vector recombinante para suprimir la proliferación de células del papilomavirus humano que incluyen el gen del polipéptido activador de la adenilato ciclasa 1 (hipófisis) y composición farmacéutica para tratar el papilomavirus humano |
| KR20150143440A (ko) * | 2013-02-15 | 2015-12-23 | 토마스 제퍼슨 유니버시티 | 떨어져 나가거나 순환 중인 종양세포를 생물학적 유액 내에서 탐지하는 방법 |
| CA2901231C (en) * | 2013-02-15 | 2020-06-23 | Thomas Jefferson University | Kit comprising lyophilized compositions for tumor imaging |
| JP2016528299A (ja) * | 2013-08-22 | 2016-09-15 | ロバート・ドイルＲｏｂｅｒｔ ＤＯＹＬＥ | ビタミンｂ１２および内因子を含む組成物およびその使用方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5997844A (en) * | 1991-02-08 | 1999-12-07 | Diatide, Inc. | Technetium-99m labeled peptides for imaging |
| US5849261A (en) * | 1991-02-08 | 1998-12-15 | Diatide, Inc. | Radiolabeled vasoactive intestinal peptides for diagnosis and therapy |
| US5965107A (en) * | 1992-03-13 | 1999-10-12 | Diatide, Inc. | Technetium-99m labeled peptides for imaging |
| US6107459A (en) * | 1991-02-08 | 2000-08-22 | Diatide, Inc. | Technetium-99m labeled peptides for diagnostic imaging |
| US5508020A (en) * | 1992-06-05 | 1996-04-16 | Diatech, Inc. | Technetium-99M labeled peptides for imaging |
| US6165755A (en) * | 1997-01-23 | 2000-12-26 | University Of Victoria Innovation And Development Corporation | Chicken neuropeptide gene useful for improved poultry production |
| US6395255B1 (en) * | 1998-06-15 | 2002-05-28 | Thomas Jefferson University | Radiolabeled vasoactive intestinal peptide analogs for imaging and therapy |
-
2002
- 2002-10-21 JP JP2003535832A patent/JP2005514335A/ja active Pending
- 2002-10-21 WO PCT/US2002/033904 patent/WO2003033030A1/en not_active Ceased
- 2002-10-21 IL IL16133202A patent/IL161332A0/xx unknown
- 2002-10-21 US US10/279,554 patent/US6855308B2/en not_active Expired - Lifetime
- 2002-10-21 RU RU2004115104/14A patent/RU2004115104A/ru not_active Application Discontinuation
- 2002-10-21 KR KR10-2004-7005539A patent/KR20040055784A/ko not_active Withdrawn
- 2002-10-21 CA CA2464002A patent/CA2464002C/en not_active Expired - Lifetime
- 2002-10-21 CN CNA028206819A patent/CN1571680A/zh active Pending
- 2002-10-21 EP EP02776270A patent/EP1441773A1/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007523881A5 (enExample) | ||
| CY1105707T1 (el) | Συνδυασμοι φορμοτερολης και ενος αλατος τριοτροπιου | |
| JP2005529847A5 (enExample) | ||
| RU2012110592A (ru) | Соединения и способ снижения мочевой кислоты | |
| BR0015908A (pt) | Emprego de compostos org nicos no tratamento de doenças | |
| RU2005126412A (ru) | Сор1 для лечения воспалительных заболеваний кишечника | |
| JP2009500443A5 (enExample) | ||
| JP2015524444A5 (enExample) | ||
| JP2002532432A5 (enExample) | ||
| JP2002532392A5 (enExample) | ||
| JP2006526590A5 (enExample) | ||
| JP2014521658A5 (enExample) | ||
| BE901073A (fr) | Composition antidiuretique a usage oral. | |
| WO2006017505A3 (en) | Pharmaceutical formulations comprising pleconaril for the treatment of airway diseases | |
| TR200101633T2 (tr) | Farmasötik bileşim | |
| JP2006514116A5 (enExample) | ||
| JP2005508963A5 (enExample) | ||
| JP2007509146A5 (enExample) | ||
| JP2002540148A5 (enExample) | ||
| Kirkwood et al. | Interferon alfa-2a for melanoma metastases | |
| JP2008517991A5 (enExample) | ||
| JP2004538314A5 (enExample) | ||
| RU2005131578A (ru) | Аплидин для лечения множественной миеломы | |
| JP2005505605A5 (enExample) | ||
| WO2005056520A8 (en) | Somatostatin receptor subtype 1 (sstr1) active compounds and their use in therapy |